Théa, Aspec, Merck Molsheim, Lab’Safe… Contents of Industrie Pharma 147

Contents of the new issue ofIndustry Pharma :

“Théa must consolidate on the American market”. Interview with Jean-Frédéric Chibret, its CEO. Specializing in ophthalmology, Théa laboratories have made a name for themselves in the French pharmaceutical industry. Update with its manager on the laboratory’s strategy.

VOS INDICES

The GALA platform innovates from Albi. Report within the platform dedicated to the transfer of technology in galenics. The galenic continues to innovate, like the Gala platform which is celebrating its tenth anniversary in the Tarn.

Clean Rooms Dossier: Maintaining the momentum

After two years of intense activity, what future for the clean room market in pharma? The sector hopes to maintain the momentum to pass without incident the risk of a slowdown, expected but hoped to be temporary.

Analyse – « 2022 has been a very mixed year »according to Xerfi

Investment – Merck increases its surfaces in Molsheim

Formation – « It is important to remember the basics »according to Stéphane Ortu of Aspec

EPI- Kolmi Hopen wants to dress pharma from head to toe

Disinfection – Lab’Safe wants to extend the use of plasma

And all the latest news from labs, biotechs, cdmo, suppliers, drugs, sector, the molecule of the month, the technical notebook, the agenda, the appointments..

Also discover the leafable version of your magazine

Selected for you

Clean room: “It is important to remember the fundamentals”, according to Stéphane Ortu (Aspec)

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.